Efficacy and Safety of Pre-Exposure Prophylaxis to Control HIV and Sexually Transmitted Infection Among Men Who Have Sex With Men: Protocol for a Single-Arm Interventional Study

BACKGROUND: Pre-exposure prophylaxis (PrEP) against HIV infection is a new approach that involves the prophylactic use of the anti-HIV drug Truvada (tenofovir disoproxil fumarate [TDF] and emtricitabine [FTC]) by people not infected with HIV. OBJECTIVE: The objective of this investigator-initiated c...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada-Hirashima, Junko, Mizushima, Daisuke, Takano, Misao, Tokita, Daisuke, Oka, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687690/
https://www.ncbi.nlm.nih.gov/pubmed/37966880
http://dx.doi.org/10.2196/50919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687690/
https://www.ncbi.nlm.nih.gov/pubmed/37966880
http://dx.doi.org/10.2196/50919

Ejemplares similares